← Back to All Filings
ResMed Director Peter Farrell Sells $227.7K in Stock via Rule 10b5-1 Plan
RESMED INC
$RMD4CIK: 0000943819
Subscribe to track RMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 ResMed Inc. ($RMD) - Insider Sale Insider: Peter C. Farrell (Director / Chairman Emeritus) Transaction: Sold 970 shares @ $234.73 ($227,688.10) Ownership After: 51,803 shares (Direct) Plan: Rule 10b5-1 plan adopted August 12, 2025 Filing Date: September 4, 2026
Comprehensive Analysis
Insider Transaction Summary
- Reporting Owner: Peter C. Farrell, Director & Chairman Emeritus
- Issuer: ResMed Inc. ($RMD)
- Transaction Date: September 2, 2026
- Transaction Type: Open market sale (Code:
S) - Shares Sold: 970 shares at an average price of $234.73 per share
- Total Transaction Value: $227,688.10
- Post-Transaction Holdings: 51,803 shares held directly
Notable Highlights
- Rule 10b5-1 Trading Plan: The transaction was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on August 12, 2025.
- Significance: Low. The sale represents approximately 1.8% of the insider's direct holdings prior to the transaction and was conducted under an established trading plan.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.